Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10441655 Monoclonal antibodies to programmed death 1 (PD-1)

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
October 7, 2016
Date of Patent
October 15, 2019
Patent Application Number
15288545
Patent Citations
‌
US Patent 10323093 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
‌
US Patent 10072082 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
Patent Citations Received
‌
US Patent 11345752 Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
‌
US Patent 11919957 Methods of treating tumor
0
‌
US Patent 11512130 Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
‌
US Patent 11530267 Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
‌
US Patent 11236163 Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
‌
US Patent 11236164 Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
‌
US Patent 11236165 Human antibodies that bind Lymphocyte Activation Gene-3 (LAG-3), and uses thereof
‌
US Patent 11566073 Methods of treating a tumor using an anti-PD-1 antibody
‌
US Patent 10988536 Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
‌
US Patent 10988535 Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10441655
Patent Primary Examiner
‌
Ilia I Ouspenski

Find more entities like US Patent 10441655 Monoclonal antibodies to programmed death 1 (PD-1)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo